carl @physioo

a standing ovation for daraxonrasib at asco. over 40k oncologists, entrepreneurs, investors, and patient advocates together celebrating revmed's breakthru in the fight against pancreatic cancer. u never forget these moments. it's what innovation is all about.

84 876 5K 2.0M 576

0 0 1 199 0

View Details

carl @physioo

3 weeks ago

@adrscib @TheTennisLetter It’s his racket ta :))

0 0 0 10 0

View Details

carl @physioo

3 weeks ago

@adrscib Hype is the game

0 0 0 77 0

View Details

carl @physioo

3 weeks ago

@adrscib @breakpointjoel Hehe Ala z

0 0 0 10 0

View Details

carl @physioo

3 weeks ago

@adrscib @TheTennisLetter Ask van

0 0 0 5 0

View Details

carl @physioo

3 weeks ago

@adrscib @TheTennisLetter Hehehe shun

2 0 0 33 0

View Details

carl @physioo

3 weeks ago

@jmgmoron JM Cerúndolo-Berrettini: 0-100 Tiafoe-Arnaldi: 100-0 Aliassime-Tabilo: 0-100 Cobolli-Svajda: 100-0 Mensik-Rublev: 100-0 Ruud-Fonseca: 0-100 Jódar-Carreño: 100-0 De Jong-Zverev: 0-100

0 0 0 314 0

View Details

carl @physioo

3 weeks ago

@BiotechCH @cngarabedian @BrianSkorney @soowannaway @Ginkgo @jrkelly @endpts @EricSchmidt151 @SamFazeli8 @gline @daphnezohar @JMaraganore @LifeSciVC @bradloncar @MatteisPaul @t_lorriman @TimOpler Nothing on celcuity late breaker?

0 0 1 188 0

View Details

carl @physioo

3 weeks ago

@Andre_AGTC @tarrikzaid Pdufa usually comes after hours so the July 17th will not cover the pdufa unless approval comes early than expected

1 0 1 154 0

View Details

carl @physioo

3 weeks ago

@FidelisAurelius Very true Some stellar bios from last year I owned Krys and sold early Traded Rvmd too and got scared prior to data! Binaries tend to scare me!

0 0 0 137 0

View Details

carl @physioo

3 weeks ago

$celc This is what intrigues me about celcuity We have data in a few days with potential of 14 -15 months mpfs making this drug one of the best out there More importantly, drug approval getting close so I am not sure how we are trading at $130 with imminent data and approval

GPF @breakeneven

2 months ago

3/ ASCO June2, PDUFA July17. The mutant data being positive means docs dont even need to check for the mutation, except for prognosis. I suspect docs will Rx mutant pts in July when drug approved, so this will jump start the launch.